Personalized care approach for patients with suspected sepsis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of various biomarkers and molecular biological methods in diagnosing sepsis among patients admitted to the emergency department. It will include approximately 1500 adult patients who are suspected of having sepsis and are managed by specialized rapid response teams. The study will also focus on identifying novel sepsis endotypes to enhance personalized treatment strategies. Informed consent will be obtained from participants, and the study will take place over a three-year period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* admitted to emergency department OUH, Ullevål.
* managed by the medical rapid response team or the sepsis rapid response team

Exclusion Criteria:

* Not given informed consent by patient or next of kin (if patient is not able to)

Where it's running

• Oslo University Hospital
  Oslo, Norway Recruiting

Study contacts

• Principal investigator: Aleksander R Holten, PhD — Oslo University Hospital
• Study coordinator: Aleksander R Holten, PhD
• Email: aleksander.holten@gmail.com
• Phone: +4799275784

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Identifying Prognostic Markers in Sepsis

  This study is trying to find new signs in the blood that can help predict which patients with severe sepsis might develop septic shock after major surgery.

  Recruiting Assistance Publique Hopitaux De Marseille · Marseille, Bouches du Rhône · NCT06446947

• Identifying biomarkers for diagnosing sepsis in the emergency room

  This study is trying to find out if certain immune responses can help doctors spot sepsis in patients with infections when they arrive at the emergency room.

  Recruiting at 2 sites Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Almere Stad, Flevoland and 2 other locations · NCT06178822

• Reducing unnecessary vancomycin use in children with suspected sepsis

  This study is testing a new approach to see if better guidelines and education can help doctors use less vancomycin in children suspected of having sepsis, which could lower the risk of kidney problems.

  Recruiting at 4 sites Children's Hospital of Philadelphia · Atlanta, Georgia and 3 other locations · NCT05975671

• Non-invasive hemodynamic guidance for sepsis care on medical wards

  This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.

  Recruiting at 2 sites Regione del Veneto - AULSS n. 7 Pedemontana · Pisa, Pisa and 1 other locations · NCT07863323

• Personalized Fluid Resuscitation in the Emergency Department

  This pilot test checks if a quick, non-invasive stroke-volume assessment can help ED doctors tailor IV fluids for septic patients with low blood pressure.

  Recruiting Intermountain Health Care, Inc. · Murray, Utah · NCT07779720

• Discordance between capillary refill time and oxygen use in septic shock

  This study tests whether some septic shock patients can have a normal capillary refill time but still lack tissue oxygen use, to see if that mismatch relates to 28-day survival.

  Recruiting Istanbul University - Cerrahpasa · Istanbul · NCT07774962

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.